Initial evidence for the importance of lymphatic transport in immune surveillance in melanoma came from murine studies where the lymphangiogenic growth factor, vascular endothelial growth factor (VEGF-C), was overexpressed in melanoma cells and implanted into immune competent hosts [64]. Here, VEGFA is linked to melanoma.